Indeed the reduced circulating levels of BPIFB4 in patients with severe disease (characterized by elevated levels of CRP and LDH) validate its prognostic significance for severity in patients with COVID-19 (Figures 1 and 2). This evidence concerns the gene BPIFB4 and COVID-19.